{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:50:54Z","timestamp":1791337854809,"version":"4.3.1"},"update-to":[{"DOI":"10.1002\/14651858.cd003724.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2008,1,23]],"date-time":"2008-01-23T00:00:00Z","timestamp":1201046400000}}],"reference-count":84,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003724.pub3","type":"journal-article","created":{"date-parts":[[2008,2,5]],"date-time":"2008-02-05T20:11:33Z","timestamp":1202242293000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Antidepressant drugs for narcolepsy"],"prefix":"10.1002","volume":"2010","author":[{"given":"Luca","family":"Vignatelli","sequence":"first","affiliation":[{"name":"Agenzia Sanitaria e Sociale Regionale - Emilia-Romagna; Osservatorio Regionale per l'Innovazione; Viale Aldo Moro 21 Bologna Italy 40128"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"D'Alessandro","sequence":"additional","affiliation":[{"name":"University of Bologna; Department of Neurological Sciences; Via Ugo Foscolo 7 40123 Bologna Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia","family":"Candelise","sequence":"additional","affiliation":[{"name":"Universita degli Studi di Milano, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena; Dipartimento di Scienze Neurologiche; Milano Italy 20122"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,1,23]]},"reference":[{"key":"10.1002\/14651858.CD003724.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/sleep\/14.2.130","article-title":"Ritanserin, a 5-ht2 receptor blocker, as add-on treatment in narcolepsy","volume":"14","author":"Lammers","year":"1991","journal-title":"Sleep"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1055\/s-2003-41200","article-title":"Ritanserin improves sleep quality in narcolepsy","volume":"36","author":"Mayer","year":"2003","journal-title":"Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/sleep\/9.1.275","article-title":"Viloxazine hydrochloride in narcolepsy: a preliminary report","volume":"9","author":"Guilleminault","year":"1986","journal-title":"Sleep"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0006|cit4","first-page":"435","article-title":"Alerting drugs: do they really work?","volume":"23","author":"Mitler","year":"1987","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/sleep\/14.3.218","article-title":"Relative efficacy of drugs for the treatment of sleepiness in narcolepsy","volume":"14","author":"Mitler","year":"1991","journal-title":"Sleep"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0004|cit6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00004691-199001000-00008","article-title":"Narcolepsy","volume":"7","author":"Mitler","year":"1990","journal-title":"Journal of Clinical Neurophysiology"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1136\/jnnp.43.2.171","article-title":"Fluvoxamine and clomipramine in the treatment of cataplexy","volume":"43","author":"Schachter","year":"1980","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1600-0404.1986.tb03518.x","article-title":"The treatment of accessory symptoms in narcolepsy: a double-blind cross-over study of a selective serotonin re-uptake inhibitor (femoxetine) versus placebo","volume":"74","author":"Schrader","year":"1986","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0009|cit9","unstructured":"Anonymous Sodium oxybate: new drug. Fewer attacks of cataplexy in some patients Prescrire International 2007 98 101"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0010|cit10","doi-asserted-by":"crossref","unstructured":"Black J Houghton WC Sodium oxybate improves excessive daytime sleepiness in narcolepsy Sleep 2006 939 46","DOI":"10.1093\/sleep\/29.7.939"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0011|cit11","doi-asserted-by":"crossref","unstructured":"Black J Pardi D Hornfeldt CS Inhaber N The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy Sleep Medicine 2009 829 35","DOI":"10.1016\/j.sleep.2009.05.004"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0012|cit12","doi-asserted-by":"crossref","unstructured":"Harsh JR Hayduk R Rosenberg R Wesnes KA Walsh JK Arora S The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy Current medical research and opinion 2006 761 74","DOI":"10.1185\/030079906X100050"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF00212777","article-title":"Effects of protriptyline on vigilance and information processing in narcolepsy","volume":"95","author":"Henry","year":"1988","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0014|cit14","doi-asserted-by":"crossref","unstructured":"Izzi F Placidi F Marciani MG Zannino S Torelli F Corte F Effective treatment of narcolepsyG\u00c7\u00f4cataplexy with duloxetine: A report of three cases Sleep Medicine 2009 153 4","DOI":"10.1016\/j.sleep.2007.11.014"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0015|cit15","doi-asserted-by":"crossref","unstructured":"Joo EY Seo DW Tae WS Hong SB Effect of modafinil on cerebral blood flow in narcolepsy patients Sleep 2008 868 73","DOI":"10.1093\/sleep\/31.6.868"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0016|cit16","doi-asserted-by":"crossref","unstructured":"Lin JS Dauvilliers Y Arnulf I Bastuji H Anaclet C Parmentier R An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin-\/- mice and patients Neurobiology of disease 2008 74 83","DOI":"10.1016\/j.nbd.2007.12.003"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/sleep\/9.1.260","article-title":"Treatment of narcolepsy: Objective studies on methylphenidate, pemoline, and protriptyline","volume":"9","author":"Mitler","year":"1986","journal-title":"Sleep"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1089\/cap.2008.036","article-title":"Treatment with venlafaxine in six cases of children with narcolepsy and with cataplexy and hypnagogic hallucinations","volume":"19","author":"Moller","year":"2009","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.sleep.2008.04.004","article-title":"Exacerbation of cataplexy following gradual withdrawal of antidepressants: Manifestation of probable protracted rebound cataplexy","volume":"10","author":"Ristanovic","year":"2009","journal-title":"Sleep Medicine"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0020|cit20","doi-asserted-by":"crossref","unstructured":"Saletu M Anderer P Saletu-Zyhlarz GM Mandl M Saletu B Zeitlhofer J Modafinil improves information processing speed and increases energetic resources for orientation of attention in narcoleptics: double-blind, placebo-controlled ERP studies with low-resolution brain electromagnetic tomography (LORETA) Sleep Medicine 2009 850 8","DOI":"10.1016\/j.sleep.2008.12.005"},{"issue":"Supplement 1","key":"10.1002\/14651858.CD003724.pub3-BIB0021|cit21","first-page":"217","article-title":"Venlafaxine in the treatment of the narcoleptic syndrome","volume":"5","author":"Smith","year":"1996","journal-title":"Journal of Sleep Research"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0022|cit22","first-page":"174","article-title":"Cataplexy treated with escitalopram - Clinical experience","volume":"27","author":"Sonka","year":"2006","journal-title":"Neuroendocrinology Letters"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0023|cit23","doi-asserted-by":"crossref","unstructured":"Weaver TE Cuellar N A randomized trial evaluating the effectiveness of sodium oxybate therapy on quality of life in narcolepsy Sleep 2006 1189 94","DOI":"10.1093\/sleep\/29.9.1189"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0024|cit24","doi-asserted-by":"crossref","unstructured":"Xyrem International Study Group A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy Journal of Clinical Sleep Medicine 2005 391 7","DOI":"10.5664\/jcsm.26368"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0025|cit25","volume-title":"International Classification of Sleep Disorders, revised: Diagnostic and Coding Manual","author":"American Academy of Sleep","year":"2001"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0026|cit26","volume-title":"ICSD-2 - International Classification of Sleep Disorders. Diagnostic and Coding Manual","author":"American Academy of Sleep","year":"2005"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0027|cit27","first-page":"77","article-title":"Validation of a cataplexy questionnaire in 983 sleep-disorders patients","volume":"22","author":"Anic-Labat","year":"1999","journal-title":"Sleep"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/sleep\/22.6.757","article-title":"Health-related quality of life effects of modafinil for treatment of narcolepsy","volume":"22","author":"Beusterien","year":"1999","journal-title":"Sleep"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1017\/S0317167100043419","article-title":"Life effects of narcolepsy in 180 patients from North America, Asia and Europe compared to matched controls","volume":"8","author":"Broughton","year":"1981","journal-title":"Canadian Journal of Neurological Science"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1017\/S0317167100044723","article-title":"Life effects of narcolepsy: relationships to geographic origin (North American, Asian or European) and to other patient and illness variables","volume":"10","author":"Broughton","year":"1983","journal-title":"Canadian Journal of Neurological Science"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1365-2869.1995.tb00159.x","article-title":"Treatment in the narcoleptic syndrome: Self assessment of the action of dexamphetamine and clomipramine","volume":"4","author":"Chen","year":"1995","journal-title":"Journal of Sleep Research"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1365-2869.2001.00234.x","article-title":"Health-related quality of life in narcolepsy","volume":"10","author":"Daniels","year":"2001","journal-title":"Journal of Sleep Research"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1212\/WNL.57.11.2029","article-title":"Age at onset of narcolepsy in two large populations of patients in France and Quebec","volume":"57","author":"Dauvilliers","year":"2001","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0140-6736(07)60237-2","article-title":"Narcolepsy with cataplexy","volume":"369","author":"Dauvilliers","year":"2007","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0013-4694(97)00010-2","article-title":"A normative study of the maintenance of wakefulness test (MWT)","volume":"103","author":"Doghramji","year":"1997","journal-title":"Electroencephalography and Clinical Neurophysiology"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1600-0404.2006.00594.x","article-title":"Health-related quality of life in narcolepsy","volume":"114","author":"Ervik","year":"2006","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0038|cit38","unstructured":"EURORDIS. Rare diseases; understanding this public health priority. www.eurordis.org\/article.php3?id_article=918, (accessed 13 June 2007)"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1378\/chest.108.3.619","article-title":"Vigilance and automobile accidents in patients with sleep apnea or narcolepsy","volume":"108","author":"Findley","year":"1995","journal-title":"Chest"},{"issue":"4","key":"10.1002\/14651858.CD003724.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1212\/WNL.44.4.707","article-title":"Fluoxetine suppresses human cataplexy: A pilot study","volume":"44","author":"Frey","year":"1994","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/sleep\/19.9.711","article-title":"Comparison of simulated driving performance in narcolepsy and sleep apnea patients","volume":"19","author":"George","year":"1996","journal-title":"Sleep"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00002826-198602000-00004","article-title":"The effect of zimelidine, a serotonin-reuptake blocker, on cataplexy and daytime sleepiness of narcoleptic patients","volume":"9","author":"Godbout","year":"1986","journal-title":"Clinical Neuropharmacology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003724.pub3-BIB0043|cit43","first-page":"31","article-title":"The influence of clinical symptoms on quality of life in patients with narcolepsy","volume":"50","author":"Goswami","year":"1998","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1600-0404.1976.tb07621.x","article-title":"Evaluation of short-term and long-term treatment of the narcolepsy syndrome with clomipramine hydrochloride","volume":"54","author":"Guilleminault","year":"1976","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0045|cit45","first-page":"676","article-title":"Narcolepsy","volume-title":"Principles and Practice of Sleep Medicine","author":"Guilleminault","year":"2000"},{"issue":"3","key":"10.1002\/14651858.CD003724.pub3-BIB0046|cit46","article-title":"Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]","author":"Higgins","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0022-510X(66)90001-3","article-title":"Treatment of narcolepsy with imipramine (tofranil) and desmethylimipramine (pertofran)","volume":"3","author":"Hishikawa","year":"1966","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1365-2869.1993.tb00096.x","article-title":"Treatment of narcolepsy-cataplexy syndrome with the new selective and reversible MAO-A inhibitor brofaromine - a pilot study","volume":"2","author":"Hohagen","year":"1993","journal-title":"Journal of Sleep Research"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1365-2869.1994.tb00104.x","article-title":"The Ullanlinna Narcolepsy Scale: validation of a measure of symptoms in the narcoleptic syndrome","volume":"3","author":"Hublin","year":"1994","journal-title":"Journal of Sleep Research"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1087-0792(98)90050-8","article-title":"Rethinking the assessment of sleepiness","volume":"2","author":"Johns","year":"1998","journal-title":"Sleep Medicine Reviews"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0006-3223(98)00111-5","article-title":"Psychometric evaluation of daytime sleepiness and nocturnal sleep onset scales in a representative community sample","volume":"45","author":"Johnson","year":"1999","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/9780470693926.ch5","article-title":"Assessing the quality of randomised controlled trials","volume-title":"Systematic Reviews in Health Care: meta-analysis in context","author":"J\u00fcni","year":"2001"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/archneur.1982.00510150039009","article-title":"Narcolepsy-cataplexy. II Psychosocial consequences and associated psychopathology","volume":"39","author":"Kales","year":"1982","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/sleep\/9.2.371","article-title":"Fluoxetine in the treatment of cataplexy","volume":"9","author":"Langdon","year":"1986","journal-title":"Sleep"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/sleep\/24.3.282","article-title":"Stimulant and anticataplectic effects of reboxetine in patients with narcolepsy: a pilot study","volume":"24","author":"Larrosa","year":"2001","journal-title":"Sleep"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/9780470693926.ch4","article-title":"Identifying randomised trials","volume-title":"Systematic Reviews in Health Care: meta-analysis in context","author":"Lefebvre","year":"2001"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0057|cit57","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 (updated September 2009). The Cochrane Collaboration, 2009. Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/sleep\/24.5.603","article-title":"Practice parameters for the treatment of narcolepsy: an update for 2000","volume":"24","author":"Littner","year":"2001","journal-title":"Sleep"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0059|cit59","volume-title":"Martindale, The Extra Pharmacopoeia","author":"Reynolds","year":"1996"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0060|cit60","first-page":"663","article-title":"Pathophysiology of Narcolepsy","volume-title":"Principles and Practice of Sleep Medicine","author":"Mignot","year":"2000"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1086\/318799","article-title":"Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups","volume":"68","author":"Mignot","year":"2001","journal-title":"American Journal of Human Genetics"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0062|cit62","first-page":"435","article-title":"Alerting drugs: do they really work?","volume":"23","author":"Mitler","year":"1987","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00004691-199001000-00008","article-title":"Narcolepsy","volume":"7","author":"Mitler","year":"1990","journal-title":"Journal of Clinical Neurophysiology"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/sleep\/14.3.218","article-title":"Relative efficacy of drugs for the treatment of sleepiness in narcolepsy","volume":"14","author":"Mitler","year":"1991","journal-title":"Sleep"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/sleep\/17.suppl_8.S103","article-title":"Narcolepsy and its treatment with stimulants. ASDA Standards of Practice","volume":"17","author":"Mitler","year":"1994","journal-title":"Sleep"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1053\/smrv.1999.0069","article-title":"Narcolepsy: genetic predisposition and neuropharmacological mechanisms","volume":"4","author":"Nishino","year":"2000","journal-title":"Sleep Medicine Reviews"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0067|cit67","unstructured":"Orphanet What is an orphan drug? http:\/\/www.orpha.net\/"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(79)92495-4","article-title":"Clomipramine and clonazepam in cataplexy","volume":"2","author":"Parkes","year":"1979","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1046\/j.1365-2869.1998.00093.x","article-title":"The clinical diagnosis of the narcoleptic syndrome","volume":"7","author":"Parkes","year":"1998","journal-title":"Journal of Sleep Research"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0070|cit70","first-page":"558","article-title":"Epidemiology of Sleep Disorders","volume-title":"Principles and Practice of Sleep Medicine","author":"Partinen","year":"2000"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0071|cit71","first-page":"173","article-title":"Sleep privation with eye movements using antidepressive agents","volume":"127","author":"Passouant","year":"1972","journal-title":"Revue Neurologique"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/0006-3223(93)90070-T","article-title":"The Sleep-Wake Activity Inventory: a self-report measure of daytime sleepiness","volume":"34","author":"Rosenthal","year":"1993","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0073|cit73","first-page":"52","article-title":"The influence of imipramine, dexphenmetrazine and amphetamine-sulphate on the composition of diurnal sleep of narcoleptics","volume":"16","author":"Roth","year":"1974","journal-title":"Activitas Nervosa Superior (Praha)"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1176\/ajp.134.2.183","article-title":"Protriptyline: an effective agent in the treatment of the narcolepsy-cataplexy syndrome and hypersomnia","volume":"134","author":"Schmidt","year":"1977","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0075|cit75","first-page":"99","article-title":"Treatment of cataplexy with clomipramine","volume":"99","author":"Shapiro","year":"1974","journal-title":"Transaction of the American Neurological Association"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1001\/archneur.1975.00490520023002","article-title":"Treatment of Cataplexy with Clomipramine","volume":"32","author":"Shapiro","year":"1975","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/sleep\/25.2.197","article-title":"The epidemiology of narcolepsy in Olmsted County, Minnesota: a population-based study","volume":"25","author":"Silber","year":"2002","journal-title":"Sleep"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.sleep.2004.07.001","article-title":"Functional status in patients with narcolepsy","volume":"5","author":"Teixeira","year":"2004","journal-title":"Sleep Medicine"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/sleep\/15.3.268","article-title":"The clinical use of the Multiple Sleep Latency Test. The Standards of Practice Committee of the American Sleep Disorders Association","volume":"15","author":"Thorpy","year":"1992","journal-title":"Sleep"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.sleep.2004.04.003","article-title":"Health-related quality of life in Italian patients with narcolepsy: the Sf-36 health survey","volume":"5","author":"Vignatelli","year":"2004","journal-title":"Sleep Medicine"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0081|cit81","first-page":"835","article-title":"An instrument to measure functional status outcomes for disorders of excessive sleepiness","volume":"20","author":"Weaver","year":"1997","journal-title":"Sleep"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1053\/smrv.2001.0152","article-title":"Outcome measurement in sleep medicine practice and research. Part 1: assessment of symptoms, subjective and objective daytime sleepiness, health-related quality of life and functional status","volume":"5","author":"Weaver","year":"2001","journal-title":"Sleep Medicine Reviews"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/alcalc\/35.4.384","article-title":"The effects of ritanserin on mood, sleep, vigilance, clinical impression, and social functioning in alcohol-dependent individuals","volume":"35","author":"Wiesbeck","year":"2000","journal-title":"Alcohol"},{"key":"10.1002\/14651858.CD003724.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM197110282851802","article-title":"Treatment of intractable narcolepsy with a monoamine oxidase inhibitor","volume":"285","author":"Wyatt","year":"1971","journal-title":"New England Journal of Medicine"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD003724.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T06:01:59Z","timestamp":1753077719000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003724.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Epilepsy Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2008,1,23]]},"references-count":84,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2010,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003724.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,23]]}}}